The transcription factor Ehf is involved in TGF-β-induced suppression of FcεRI and c-kit expression and FcεRI-mediated activation in mast cells

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 3427-3435

  Yamazaki, Susumu ^a   Nakano, Nobuhiro ^a   Honjo, Asuka ^a   Hara, Mutsuko ^a   Maeda, Keiko ^a   Nishiyama, Chiharu ^a,b   Kitaura, Jiro ^a   Ohtsuka, Yoshikazu ^a   Okumura, Ko ^a   Ogawa, Hideoki ^a   Shimizu, Toshiaki ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; FC EPSILON RI ALPHA PROTEIN; FC EPSILON RI BETA PROTEIN; FC EPSILON RI PROTEIN; FC RECEPTOR; MESSENGER RNA; SMAD PROTEIN; STAT5B PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR EHF; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; EHF PROTEIN, MOUSE; FC-EPSILON RECEPTOR I BETA-CHAIN, MOUSE; FCEPSILONRIALPHA PROTEIN, MOUSE; GATA1 PROTEIN, MOUSE; GATA2 PROTEIN, MOUSE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; SMALL INTERFERING RNA; STAT5 PROTEIN; STAT5B PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MAST CELL; CELL ACTIVATION; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; GATA1 GENE; GATA2 GENE; GENE ACTIVITY; GENE REPRESSION; HUMAN; HUMAN CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; STAT5B GENE; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; DEGRANULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; MAST CELL; METABOLISM; RNA INTERFERENCE; TRANSCRIPTION INITIATION;

ANIMALS; BONE MARROW CELLS; CELL DEGRANULATION; CELLS, CULTURED; CYTOKINES; GATA1 TRANSCRIPTION FACTOR; GATA2 TRANSCRIPTION FACTOR; IMMUNOGLOBULIN E; MAST CELLS; MICE; MICE, INBRED BALB C; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, IGE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84942465515     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402856     Document Type: Article

References (44)

1. Nishiyama, C., T. Yokota, K. Okumura, and C. Ra. 1999. The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor a-chain gene. J. Immunol. 163: 623-630.
2. Nishiyama, C., M. Hasegawa, M. Nishiyama, K. Takahashi, Y. Akizawa, T. Yokota, K. Okumura, H. Ogawa, and C. Ra. 2002. Regulation of human FcεRIa-chain gene expression by multiple transcription factors. J. Immunol. 168: 4546-4552.
3. Maeda, K., C. Nishiyama, T. Tokura, Y. Akizawa, M. Nishiyama, H. Ogawa, K. Okumura, and C. Ra. 2003. Regulation of cell type-specific mouse FcεRI b-chain gene expression by GATA-1 via four GATA motifs in the promoter. J. Immunol. 170: 334-340.
4. Takahashi, K., C. Nishiyama, M. Hasegawa, Y. Akizawa, and C. Ra. 2003. Regulation of the human high affinity IgE receptor b-chain gene expression via an intronic element. J. Immunol. 171: 2478-2484.
5. Maeda, K., C. Nishiyama, T. Tokura, H. Nakano, S. Kanada, M. Nishiyama, K. Okumura, and H. Ogawa. 2006. FOG-1 represses GATA-1-dependent FcεRIb-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice. Blood 108: 262-269.
6. Nishiyama, C. 2006. Molecular mechanism of allergy-related gene regulation and hematopoietic cell development by transcription factors. Biosci. Biotechnol. Biochem. 70: 1-9.
7. Inage, E., K. Kasakura, T. Yashiro, R. Suzuki, Y. Baba, N. Nakano, M. Hara, A. Tanabe, K. Oboki, K. Matsumoto, et al. 2014. Critical roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2. J. Immunol. 192: 3936-3946.
8. Chabot, B., D. A. Stephenson, V. M. Chapman, P. Besmer, and A. Bernstein. 1988. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335: 88-89.
9. Copeland, N. G., D. J. Gilbert, B. C. Cho, P. J. Donovan, N. A. Jenkins, D. Cosman, D. Anderson, S. D. Lyman, and D. E. Williams. 1990. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63: 175-183.
10. Duttlinger, R., K. Manova, T. Y. Chu, C. Gyssler, A. D. Zelenetz, R. F. Bachvarova, and P. Besmer. 1993. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kitligand expression affects melanogenesis. Development 118: 705-717.
11. Maeda, K., C. Nishiyama, H. Ogawa, and K. Okumura. 2010. GATA2 and Sp1 positively regulate the c-kit promoter in mast cells. J. Immunol. 185: 4252-4260.
12. Gomez, G., C. D. Ramirez, J. Rivera, M. Patel, F. Norozian, H. V. Wright, M. V. Kashyap, B. O. Barnstein, K. Fischer-Stenger, L. B. Schwartz, et al. 2005. TGF-b1 inhibits mast cell FcεRI expression. J. Immunol. 174: 5987-5993.
13. Kashyap, M., D. P. Bailey, G. Gomez, J. Rivera, T. F. Huff, and J. J. Ryan. 2005. TGF-b1 inhibits late-stage mast cell maturation. Exp. Hematol. 33: 1281-1291.
14. Fernando, J., T. W. Faber, N. A. Pullen, Y. T. Falanga, E. M. Kolawole, C. A. Oskeritzian, B. O. Barnstein, G. Bandara, G. Li, L. B. Schwartz, et al. 2013. Genotype-dependent effects of TGF-b1 on mast cell function: targeting the Stat5 pathway. J. Immunol. 191: 4505-4513.
15. Miller, H. R., S. H. Wright, P. A. Knight, and E. M. Thornton. 1999. A novel function for transforming growth factor-b1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific b-chymase, mouse mast cell protease-1. Blood 93: 3473-3486.
16. Rosbottom, A., C. L. Scudamore, H. von der Mark, E. M. Thornton, S. H. Wright, and H. R. Miller. 2002. TGF-b1 regulates adhesion of mucosal mast cell homologues to laminin-1 through expression of integrin a7. J. Immunol. 169: 5689-5695.
17. Wright, S. H., J. Brown, P. A. Knight, E. M. Thornton, P. J. Kilshaw, and H. R. Miller. 2002. Transforming growth factor-b1 mediates coexpression of the integrin subunit aE and the chymase mouse mast cell protease-1 during the early differentiation of bone marrow-derived mucosal mast cell homologues. Clin. Exp. Allergy 32: 315-324.
18. Brown, J. K., P. A. Knight, S. H. Wright, E. M. Thornton, and H. R. Miller. 2003. Constitutive secretion of the granule chymase mouse mast cell protease-1 and the chemokine, CCL2, by mucosal mast cell homologues. Clin. Exp. Allergy 33: 132-146.
19. Brown, J. K., P. A. Knight, A. D. Pemberton, S. H. Wright, J. A. Pate, E. M. Thornton, and H. R. Miller. 2004. Expression of integrin-aE by mucosal mast cells in the intestinal epithelium and its absence in nematode-infected mice lacking the transforming growth factor-b1-activating integrin avb6. Am. J. Pathol. 165: 95-106.
20. Mokrani, M., J. Klibi, D. Bluteau, G. Bismuth, and F. Mami-Chouaib. 2014. Smad and NFAT pathways cooperate to induce CD103 expression in human CD8 T lymphocytes. J. Immunol. 192: 2471-2479.
21. Sharrocks, A. D. 2001. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2: 827-837.
22. Hollenhorst, P. C., L. P. McIntosh, and B. J. Graves. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu. Rev. Biochem. 80: 437-471.
23. Kas, K., E. Finger, F. Grall, X. Gu, Y. Akbarali, J. Boltax, A. Weiss, P. Oettgen, R. Kapeller, and T. A. Libermann. 2000. ESE-3, a novel member of an epithelium-specific Ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1. J. Biol. Chem. 275: 2986-2998.
24. Silverman, E. S., R. M. Baron, L. J. Palmer, L. Le, A. Hallock, V. Subramaniam, R. J. Riese, M. D. McKenna, X. Gu, T. A. Libermann, et al. 2002. Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung. Am. J. Respir. Cell Mol. Biol. 27: 697-704.
25. Taniue, K., T. Oda, T. Hayashi, M. Okuno, and T. Akiyama. 2011. A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis. EMBO Rep. 12: 682-689.
26. Albino, D., N. Longoni, L. Curti, M. Mello-Grand, S. Pinton, G. Civenni, G. Thalmann, G. D'Ambrosio, M. Sarti, F. Sessa, et al. 2012. ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Res. 72: 2889-2900.
27. Brenne, K., D. A. Nymoen, T. E. Hetland, C. G. Trope', and B. Davidson. 2012. Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival. Hum. Pathol. 43: 496-505.
28. Stephens, D. N., R. H. Klein, M. L. Salmans, W. Gordon, H. Ho, and B. Andersen. 2013. The Ets transcription factor EHF as a regulator of cornea epithelial cell identity. J. Biol. Chem. 288: 34304-34324.
29. Tugores, A., J. Le, I. Sorokina, A. J. Snijders, M. Duyao, P. S. Reddy, L. Carlee, M. Ronshaugen, A. Mushegian, T. Watanaskul, et al. 2001. The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades. J. Biol. Chem. 276: 20397-20406.
30. Appel, S., A. Bringmann, F. Grünebach, M. M. Weck, J. Bauer, and P. Brossart. 2006. Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs. Blood 107: 3265-3270.
31. Sprater, F., A. O. Hovden, and S. Appel. 2012. Expression of ESE-3 isoforms in immunogenic and tolerogenic human monocyte-derived dendritic cells. PLoS One 7: e49577.
32. Sprater, F., W. Azeem, and S. Appel. 2014. Activation of peroxisome proliferator-activated receptor g leads to upregulation of ESE-3 expression in human monocyte-derived dendritic cells. Scand. J. Immunol. 79: 20-26.
33. Razin, E., J. N. Ihle, D. Seldin, J. M. Mencia-Huerta, H. R. Katz, P. A. LeBlanc, A. Hein, J. P. Caulfield, K. F. Austen, and R. L. Stevens. 1984. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132: 1479-1486.
34. Kitamura, N., H. Yokoyama, T. Yashiro, N. Nakano, M. Nishiyama, S. Kanada, T. Fukai, M. Hara, S. Ikeda, H. Ogawa, K. Okumura, and C. Nishiyama. 2012. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells. J. Allergy Clin. Immunol. 129: 814-824.e6. doi:10.1016/j.jaci.2011.10.019
35. Nakano, N., C. Nishiyama, H. Yagita, A. Koyanagi, H. Akiba, S. Chiba, H. Ogawa, and K. Okumura. 2009. Notch signaling confers antigen-presenting cell functions on mast cells. J. Allergy Clin. Immunol. 123: 74-81.e1. doi: 10.1016/j.jaci.2008.10.040
36. Ito, T., C. Nishiyama, M. Nishiyama, H. Matsuda, K. Maeda, Y. Akizawa, R. Tsuboi, K. Okumura, and H. Ogawa. 2005. Mast cells acquire monocytespecific gene expression and monocyte-like morphology by overproduction of PU.1. J. Immunol. 174: 376-383.
37. Dubois, C. M., F. W. Ruscetti, J. Stankova, and J. R. Keller. 1994. Transforming growth factor-b regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83: 3138-3145.
38. Hasegawa, M., C. Nishiyama, M. Nishiyama, Y. Akizawa, K. Mitsuishi, T. Ito, H. Kawada, S. Furukawa, C. Ra, K. Okumura, and H. Ogawa. 2003. A novel -66T/C polymorphism in FcεRIa-chain promoter affecting the transcription activity: possible relationship to allergic diseases. J. Immunol. 171: 1927-1933.
39. Nishiyama, C., Y. Akizawa, M. Nishiyama, T. Tokura, H. Kawada, K. Mitsuishi, M. Hasegawa, T. Ito, N. Nakano, A. Okamoto, et al. 2004. Polymorphisms in the FcεRIb promoter region affecting transcription activity: a possible promoterdependent mechanism for association between FcεRIb and atopy. J. Immunol. 173: 6458-6464.
40. Nishiyama, C., T. Ito, M. Nishiyama, S. Masaki, K. Maeda, N. Nakano, W. Ng, K. Fukuyama, M. Yamamoto, K. Okumura, and H. Ogawa. 2005. GATA-1 is required for expression of FcεRI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow. Int. Immunol. 17: 847-856.
41. Kanada, S., N. Nakano, D. P. Potaczek, K. Maeda, N. Shimokawa, Y. Niwa, T. Fukai, M. Sanak, A. Szczeklik, H. Yagita, et al. 2008. Two different transcription factors discriminate the 2315C.T polymorphism of the FcRIa gene: binding of Sp1 to 2315C and of a high mobility group-related molecule to 2315T. J. Immunol. 180: 8204-8210.
42. Wang, Q. H., C. Nishiyama, N. Nakano, N. Shimokawa, M. Hara, S. Kanada, H. Ogawa, and K. Okumura. 2008. Suppressive effect of Elf-1 on FcεRI a-chain expression in primary mast cells. Immunogenetics 60: 557-563.
43. Fang, Y., T. Zhang, L. Lidell, X. Xu, N. Lycke, and Z. Xiang. 2013. The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcgRIIIA and augments anti-HPV immunity after nasal immunization. Mucosal Immunol. 6: 1168-1178.
44. Pullen, N. A., B. O. Barnstein, Y. T. Falanga, Z. Wang, R. Suzuki, T. D. Tamang, M. C. Khurana, E. A. Harry, P. Draber, K. D. Bunting, et al. 2012. Novel mechanism for FcεRI-mediated signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation and the selective influence of STAT5B over mast cell cytokine production. J. Biol. Chem. 287: 2045-2054.